Heyn R., Haeberlen V., Newton WA, et al. Second malignant neoplasms in children treated for rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee. J Clin Oncol . 1993;11:262-270.
5.
Goldsby R., Burke C., Nagarajan R., et al. Second malignant neoplasms among children, adolescents, and young adults diagnosed with malignant bone tumors since 1976: follow-up of a Children’s Oncology Group cohort. Cancer. 2008;113:2597-2604.
6.
Pedersen-Bjergaard J., Pedersen M., Roulston D., Philip P.Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia. Blood. 1995;86:3542-3552.
7.
Li FP, Fraumeni JF Jr.Soft tissue sarcomas, breast cancer and other neoplasms: a familial syndrome?Ann Intern Med. 1969;71:747-752.
8.
Li FP, Fraumeni JF Jr, Mulvihill JJ, et al. A cancer family syndrome in twenty-four kindreds. Cancer Res. 1988;48: 5358-5362.
9.
Hisada M., Garber JE, Fung CY, Fraumeni JF Jr, Li FPMultiple primary cancers in families with Li-Fraumeni syndrome. J Nat Cancer Inst. 1998;90:606-611.
10.
Lane DPCancer. P53, guardian of the genome. Nature. 1992;358:15-16.
11.
Malkin D., Li FP, Strong LC, et al. Germline p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science. 1990 ;250:1233-1238.